Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Dhirodatta Senapati"'
Autor:
Salma Ben-Salem, Qiang Hu, Yang Liu, Mohammed Alshalalfa, Xin Zhao, Irene Wang, Varadha Balaji Venkadakrishnan, Dhirodatta Senapati, Sangeeta Kumari, Deli Liu, Andrea Sboner, Christopher E. Barbieri, Felix Feng, Jean-Noel Billaud, Elai Davicioni, Song Liu, Hannelore V. Heemers
Publikováno v:
European Urology Open Science, Vol 22, Iss , Pp 34-44 (2020)
Background: Metastatic prostate cancer (CaP) treatments are evolving rapidly but without evidence-based biomarkers to predict responses, and to maximize remissions and survival. Objective: To determine the activity of androgen receptor (AR), the targ
Externí odkaz:
https://doaj.org/article/ba587ec25e6b4c92b3f6ddb1ad16913f
Publikováno v:
Asian Journal of Urology, Vol 7, Iss 3, Pp 219-232 (2020)
Prostate cancer (PCa) progression relies on androgen receptor (AR) action. Preventing AR's ligand-activation is the frontline treatment for metastatic PCa. Androgen deprivation therapy (ADT) that inhibits AR ligand-binding initially induces remission
Externí odkaz:
https://doaj.org/article/4973a60c0f9a4f73afd9b3d8af401f16
Autor:
Dhirodatta Senapati, Ritu Kushwaha, Siddhartha Dutta, Jay Prakash Maurya, Srabasthi Biswas, Sreeramaiah N. Gangappa, Sudip Chattopadhyay
Publikováno v:
Plant Direct, Vol 3, Iss 6, Pp n/a-n/a (2019)
Abstract The unique member of the calmodulin gene family, Calmodulin7 (CAM7), plays a crucial role as transcriptional regulator to promote Arabidopsis seedling development. CAM7 regulates the expression of HY5, which is intimately involved in the pro
Externí odkaz:
https://doaj.org/article/033754f2faf143d5bb76ac18187c1dc8
Autor:
Song Liu, Sangeeta Kumari, Qiang Hu, Dhirodatta Senapati, Varadha Balaji Venkadakrishnan, Dan Wang, Adam D DePriest, Simon E Schlanger, Salma Ben-Salem, Malyn May Valenzuela, Belinda Willard, Shaila Mudambi, Wendy M Swetzig, Gokul M Das, Mojgan Shourideh, Shahriah Koochekpour, Sara Moscovita Falzarano, Cristina Magi-Galluzzi, Neelu Yadav, Xiwei Chen, Changshi Lao, Jianmin Wang, Jean-Noel Billaud, Hannelore V Heemers
Publikováno v:
eLife, Vol 6 (2017)
Externí odkaz:
https://doaj.org/article/9aebacceecd24ba98796d96b142dcb42
Autor:
Song Liu, Sangeeta Kumari, Qiang Hu, Dhirodatta Senapati, Varadha Balaji Venkadakrishnan, Dan Wang, Adam D DePriest, Simon E Schlanger, Salma Ben-Salem, Malyn May Valenzuela, Belinda Willard, Shaila Mudambi, Wendy M Swetzig, Gokul M Das, Mojgan Shourideh, Shahriah Koochekpour, Sara Moscovita Falzarano, Cristina Magi-Galluzzi, Neelu Yadav, Xiwei Chen, Changshi Lao, Jianmin Wang, Jean-Noel Billaud, Hannelore V Heemers
Publikováno v:
eLife, Vol 6 (2017)
Standard treatment for metastatic prostate cancer (CaP) prevents ligand-activation of androgen receptor (AR). Despite initial remission, CaP progresses while relying on AR. AR transcriptional output controls CaP behavior and is an alternative therape
Externí odkaz:
https://doaj.org/article/41305a6fc01f416095798be8b5b7c5bf
Publikováno v:
Diabetology International. 14:134-144
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac1fccc2d12779f3371f2dbb7444b9ff
https://doi.org/10.1007/s13340-022-00607-9
https://doi.org/10.1007/s13340-022-00607-9
Autor:
Varadha Balaji Venkadakrishnan, Christopher E. Barbieri, Jean-Noel Billaud, Salma Ben-Salem, Hannelore V. Heemers, Song Liu, Elai Davicioni, Irene Wang, Sangeeta Kumari, Qiang Hu, Felix Y. Feng, Mohammed Alshalalfa, Andrea Sboner, Deli Liu, Yang Liu, Xin Zhao, Dhirodatta Senapati
Publikováno v:
European urology open science
European Urology Open Science, Vol 22, Iss, Pp 34-44 (2020)
European Urology Open Science, Vol 22, Iss, Pp 34-44 (2020)
Background Metastatic prostate cancer (CaP) treatments are evolving rapidly but without evidence-based biomarkers to predict responses, and to maximize remissions and survival. Objective To determine the activity of androgen receptor (AR), the target
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1295f92678c9ce5b610f32b29425b994
http://europepmc.org/articles/PMC7723342
http://europepmc.org/articles/PMC7723342
Autor:
Sangeeta Kumari, Vikas Sharma, Rahul Tiwari, Jay Prakash Maurya, Bharat Bhusan Subudhi, Dhirodatta Senapati
Publikováno v:
European journal of pharmacology. 919
Metastatic prostate cancer (mCaP) remains one of the leading causes of cancer-related death in men worldwide. Androgen receptor (AR) drives the progression of most of the mCaP, and hence the androgen deprivation therapy (ADT) is the first-line treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcec51455aad3f0fc6ecc2775803815d
https://pubmed.ncbi.nlm.nih.gov/35151649
https://pubmed.ncbi.nlm.nih.gov/35151649
Publikováno v:
Endocrine-Related Cancer. 24:R275-R295
With few exceptions, the almost 30,000 prostate cancer deaths annually in the United States are due to failure of androgen deprivation therapy. Androgen deprivation therapy prevents ligand-activation of the androgen receptor. Despite initial remissio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::250fd13829816e6dbece4d5a4cf5a6bb
https://doi.org/10.1530/erc-17-0121
https://doi.org/10.1530/erc-17-0121
Autor:
Rajal B. Shah, Hannelore V. Heemers, Sangeeta Kumari, Dhirodatta Senapati, Qiang Hu, Gissou Azabdaftari, Scott M. Dehm, Nima Sharifi, Varadha Balaji Venkadakrishnan, James L. Mohler, Eduardo Cortes, Yixue Su, Adam D. DePriest, Salma Ben-Salem, Eric A. Klein, Christina Jamieson, Cristina Magi-Galluzzi, Song Liu, Elena Pop, Kristopher Attwood, Giridhar Mudduluru
Sustained reliance on androgen receptor (AR) after failure of AR-targeting androgen deprivation therapy (ADT) prevents effective treatment of castration-recurrent (CR) prostate cancer (CaP). Interfering with the molecular machinery by which AR drives
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b691330c538af1059629c22c6603d892
https://europepmc.org/articles/PMC6771259/
https://europepmc.org/articles/PMC6771259/
